COSMOS HEALTH CEO Issues Letter to Shareholders

2 years ago

Company reaches major strategic inflection point, with operations and revenue ramp-up underway, to significantly accelerate in 2024 and beyondMaintains solid…

Galexxy Inks an Agreement to Integrate Hussle’s Leading Technology into Galexxy’s New APP for Rapid Business Growth

2 years ago

NEWPORT BEACH, CA / ACCESSWIRE / October 5, 2023 / Galexxy Holdings Inc., ("Galexxy" or "Company") (OTC PINK:GXXY), and Hussle.Tech,…

The Role of Vagus Nerve in the Lifestyles of Millionaires and Biohackers

2 years ago

VILNIUS, LITHUANIA / ACCESSWIRE / October 5, 2023 / The vagus nerve is a powerhouse of the human body, holding…

FSD Pharma and Celly Nu Enter Into Arrangement Agreement

2 years ago

TORONTO, ON / ACCESSWIRE / October 5, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

Theralase(R) Files US Patent for Enhanced Immunotherapy

2 years ago

Theralase®'s Latest Preclinical Data Supports Combining Immunotherapy Drugs with Theralase® PDCs for Increased Cancer DestructionTORONTO, ON / ACCESSWIRE / October…

Brüush Announces Notice from Nasdaq for Continued Listing

2 years ago

VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the "Company"), today announced that it…

Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development

2 years ago

ANN ARBOR, MI / ACCESSWIRE / October 5, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…

Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase

2 years ago

SOUTH SAN FRANCISCO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Epic Bio, a biotechnology company developing therapies to modulate gene…

Clearmind Medicine to Present at the 8th Annual Dawson James Conference on October 12th

2 years ago

Tel Aviv, Israel / Vancouver, Canada, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY)…

Study Published in Science Translational Medicine Shows Exbaq’s Experimental Vaccine Protects Against Many of the Most Dangerous Antibiotic Resistant Superbugs Causing Hospital Acquired Infections

2 years ago

Vaccine Stimulates the Body’s Macrophages, Engulfing and Killing Gram Positive/Negative Bacteria, and FungiVaccine provides protection against infections within 24hours and…